Programmed cell death ligand 1 as a biomarker in head and neck cancer

The evaluation of programmed cell death ligand 1 has a potential role in the application of immune checkpoint inhibitors for select cancers of the head and neck. See related commentary on pages 000-000.

http://ift.tt/2pdxrjY